| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |